FDA Inspection 1336336 — University Of Utah Cell Therapy And Regenerative Medicine
The FDA completed an inspection of University Of Utah Cell Therapy And Regenerative Medicine on Sep 11, 2026 in Salt Lake City, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 11, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Salt Lake City, UT (United States)